Expert Ratings For Pacira BioSciences
Expert Ratings For Pacira BioSciences
Pacira Biosciences的专家评级
Pacira BioSciences (NASDAQ:PCRX) has been analyzed by 8 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.
在过去的三个月中,有8位分析师对Pacira BioSciences(纳斯达克股票代码:PCRX)进行了分析,揭示了从看涨到看跌的不同观点。
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
下表汇总了他们最近的评级,阐明了过去30天内情绪的变化,并将其与前几个月进行了比较。
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $41.88, with a high estimate of $57.00 and a low estimate of $25.00. Highlighting a 8.72% decrease, the current average has fallen from the previous average price target of $45.88.
分析师对12个月目标股价的评估提供了更多见解,显示平均目标价为41.88美元,最高估计为57.00美元,低估值为25.00美元。当前的平均价格已从之前的45.88美元的平均目标股价有所下降,这凸显了8.72%的跌幅。
Decoding Analyst Ratings: A Detailed Look
解码分析师评级:详细介绍
An in-depth analysis of recent analyst...
对分析师近期行...
登录免费看全文
登录/注册